🔸What’s the pathophysiology of Portal Hypertension?

🔹Which therapeutic options are available or in the pipeline?

🔸Can we optimize the research in this field?

✅Answer these, and other, questions in our latest review now available The Lancet Gastroenterology & Hepatology

🆓 authors.elsevier.com/a/1ixqA8nByr8u…

✨ Truly fantastic days in #Kyoto for #APASL2024 🌸

🔖 Great scientific and social programming

✅ Lecture on underlying mechanisms of liver fibrosis and portal hypertension

🚶🏻 Enjoyable sightseeing & cuisine with Norifumi Kawada, MD, PhD team

See you all in #APASL2025 (or before!)

🆕 Fresh from the oven‼️

🤔 Curious about the role of cell #senescence in #liver diseases?

Happy to share our latest review published in Nature Reviews Gastroenterology & Hepatology

Check it out ⬇️, free reading!

Special recognition to first authors David & Albert Gibert 🫶🏼

nature.com/articles/s4157…

Today and tomorrow a group of physicians from Xina are visiting our unit. Happy to share clinical experiences and knowledge Hospital Clínic IDIBAPS CIBERehd ERN RARE LIVER LiverUnit.Clinic.BCN

🔆 Happy to strength international collaborations!

Bryan Priego from Univ. Veracruzana 🇲🇽 is a MD aimed at improving his skills in the lab.

Kirara Inoue is a PhD student from Osaka Metropolitan University Norifumi Kawada, MD, PhD 🇯🇵 who will work on ongoing collaborative projects.

Welcome to IDIBAPS CIBERehd‼️

🔴📢Jordi Gracia-Sancho, nuevo director científico del área de Enfermedades Hepáticas y Digestivas del CIBER...

🔗ciberisciii.es/noticias/jordi…

#CIBER #CIBER EHD #HEPÁTICA

Extremely happy and honored to become Fellow of AASLD ☺️

Many many thanks AASLD, mentors, lab members, worldwide colleagues and friends! And specially to my dear family!

IDIBAPS Hospital Clínic CIBERehd
#TLM23

Just few days for AASLD #Liver Meeting 2023❗️

Very much looking forward to sharing and learning science, meeting colleagues and friends, and have some fun ☺️

Find below a summary of our contributions, see you all in my loved Boston!!

#TLM2023

A great collaborative effort. Thanks to all participants IDIBAPS Hospital Clínic @CIBERehd Hepatic Hemodynamic

HOT OFF THE PRESS!

How mechanical forces impact liver health & contribute to Portal Hypertension (PH)?

✅Our latest review delves into the interplay between forces and cell responses, shedding light on potential therapies for PH.

Now in JHEP Reports

🔓sciencedirect.com/science/articl…

Can patients with MASLD cirrhosis recompensate?? Do not miss our recent review ⁦Nature Reviews Gastroenterology & Hepatology⁩ led by G Feng and MH Zheng👇🏼⁦Luca Valenti⁩ ⁦LiverUnit.Clinic.BCN⁩ nature.com/articles/s4157…

Today at the weekly meetings of the Hospital Clínic & IDIBAPS #Liver Unit:

Our Laia Abad-Jordà presenting the current results of one her PhD thesis projects.

Brilliant lecture + active Q&A, in a packed room!

Next stop for her ➡️ oral presentation at AASLD Meeting!! 👏🏼

Aquesta setmana, a l'IDIBAPS: El Clínic-IDIBAPS participa en les noves guies internacionals per al tractament de l’hemorràgia per varius esofàgiques

👉tuit.cat/N6fAk

Networking with Colleagues at the Serbian gastroenterological meeting. Hospital Clínic ERN RARE LIVER IDIBAPS Valdig Group

🤩Let’s congratulate our fellows

- Sergio Quesada got a Sara Borrell postdoc fellowship to study mechanisms of liver vascular dysfunction

- Laia Abad got a mobility fellowship to learn from Dr. Amaia Lujambio lab

Many thanks Instituto de Salud Carlos III (ISCIII) for supporting young talented scientists‼️

Join us through this excellent funding opportunity!

👩🏼‍🔬👨🏽‍⚕️👨🏻‍💻Multidisciplinary team coordinated by Manuel Romero-Gómez Javier Cubero and 🙋🏻‍♂️

🔬 Topic: Steatotic liver disease from bench to bedside, and viceversa

🏙️ 3 labs in 3 years ‼️

All info: postdoc-aristos.com/DetailGroup?Gr…

🫶🏼 Please RT 🫶🏼

A major research gap: The use of anticoagulants in cirrhosis - ScienceDirect.
⁦CIBERehd⁩ ⁦IDIBAPS⁩ ⁦Hospital Clínic⁩ sciencedirect.com/science/articl…

📬 So nice inbox today!!

4 accepted communications for the AASLD Liver Meeting 2023‼️

1 oral presentation + 3 posters❕

Extremely happy and proud of my fellows and collaborators!! 🙏🏽👊🏽

See you all in #Boston !!

#TLM #LiverTwitter #LiverX

📣 Are you interested in portal hypertension #livertwitter ?
Consider joining The Baveno Cooperation: an EASL Consortium by contacting Thomas Reiberger
See instructions below on who qualifies 👇🏼👇🏼👇🏼

📅 Join us on July 13th for a kick-off meeting of the #ARISTOS Project in #Biomedicine & #Health Sciences!🚀 ⏰ 3:00- 4:30 PM CEST. Welcomes 👥 #postdocs 🏢 interested companies register at👉 docs.google.com/forms/d/e/1FAI… Don't miss this chance! CIBER ISCIII RAICEX EURAXESS